155 related articles for article (PubMed ID: 36297384)
1. Radiosynthesis and Preclinical Evaluation of an
Wenzel B; Fritzsche SR; Toussaint M; Briel D; Kopka K; Brust P; Scheunemann M; Deuther-Conrad W
Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297384
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, 18F-Radiolabelling and Biological Characterization of Novel Fluoroalkylated Triazine Derivatives for in Vivo Imaging of Phosphodiesterase 2A in Brain via Positron Emission Tomography.
Schröder S; Wenzel B; Deuther-Conrad W; Teodoro R; Egerland U; Kranz M; Scheunemann M; Höfgen N; Steinbach J; Brust P
Molecules; 2015 May; 20(6):9591-615. PubMed ID: 26016549
[TBL] [Abstract][Full Text] [Related]
3. Radiosynthesis and Biological Investigation of a Novel Fluorine-18 Labeled Benzoimidazotriazine- Based Radioligand for the Imaging of Phosphodiesterase 2A with Positron Emission Tomography.
Ritawidya R; Wenzel B; Teodoro R; Toussaint M; Kranz M; Deuther-Conrad W; Dukic-Stefanovic S; Ludwig FA; Scheunemann M; Brust P
Molecules; 2019 Nov; 24(22):. PubMed ID: 31731831
[TBL] [Abstract][Full Text] [Related]
4. Investigation of an
Schröder S; Wenzel B; Deuther-Conrad W; Teodoro R; Kranz M; Scheunemann M; Egerland U; Höfgen N; Briel D; Steinbach J; Brust P
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498659
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and In Vitro Evaluation of 8-Pyridinyl-Substituted Benzo[
Ritawidya R; Ludwig FA; Briel D; Brust P; Scheunemann M
Molecules; 2019 Jul; 24(15):. PubMed ID: 31370274
[TBL] [Abstract][Full Text] [Related]
6. Radiosynthesis and initial characterization of a PDE10A specific PET tracer [18F]AMG 580 in non-human primates.
Hwang DR; Hu E; Allen JR; Davis C; Treanor J; Miller S; Chen H; Shi B; Narayanan TK; Barret O; Alagille D; Yu Z; Slifstein M
Nucl Med Biol; 2015 Aug; 42(8):654-63. PubMed ID: 25935386
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.
Chen L; Nabulsi N; Naganawa M; Zasadny K; Skaddan MB; Zhang L; Najafzadeh S; Lin SF; Helal CJ; Boyden TL; Chang C; Ropchan J; Carson RE; Villalobos A; Huang Y
J Nucl Med; 2016 Sep; 57(9):1448-53. PubMed ID: 27199356
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and preclinical evaluation of an 18F labeled PDE7 inhibitor for PET neuroimaging.
Thomae D; Servaes S; Vazquez N; Wyffels L; Dedeurwaerdere S; Van der Veken P; Joossens J; Augustyns K; Stroobants S; Staelens S
Nucl Med Biol; 2015 Dec; 42(12):975-81. PubMed ID: 26330158
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterases PDE2A and PDE10A both change mRNA expression in the human brain with age, but only PDE2A changes in a region-specific manner with psychiatric disease.
Farmer R; Burbano SD; Patel NS; Sarmiento A; Smith AJ; Kelly MP
Cell Signal; 2020 Jun; 70():109592. PubMed ID: 32119913
[TBL] [Abstract][Full Text] [Related]
10. Target Engagement of a Phosphodiesterase 2A Inhibitor Affecting Long-Term Memory in the Rat.
Gu G; Scott T; Yan Y; Warren N; Zhang A; Tabatabaei A; Xu H; Aertgeerts K; Gomez L; Morse A; Li YW; Breitenbucher JG; Massari E; Vivian J; Danks A
J Pharmacol Exp Ther; 2019 Sep; 370(3):399-407. PubMed ID: 31253692
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain.
Celen S; Koole M; De Angelis M; Sannen I; Chitneni SK; Alcazar J; Dedeurwaerdere S; Moechars D; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
J Nucl Med; 2010 Oct; 51(10):1584-91. PubMed ID: 20847170
[TBL] [Abstract][Full Text] [Related]
12. Towards selective phosphodiesterase 2A (PDE2A) inhibitors: a patent review (2010 - present).
Trabanco AA; Buijnsters P; Rombouts FJ
Expert Opin Ther Pat; 2016 Aug; 26(8):933-46. PubMed ID: 27321640
[TBL] [Abstract][Full Text] [Related]
13. Radiosynthesis and biological evaluation of the new PDE10A radioligand [
Wagner S; Teodoro R; Deuther-Conrad W; Kranz M; Scheunemann M; Fischer S; Wenzel B; Egerland U; Hoefgen N; Steinbach J; Brust P
J Labelled Comp Radiopharm; 2017 Jan; 60(1):36-48. PubMed ID: 27896836
[TBL] [Abstract][Full Text] [Related]
14. In Vitro and In Vivo Characterization of Selected Fluorine-18 Labeled Radioligands for PET Imaging of the Dopamine D3 Receptor.
Nebel N; Maschauer S; Kuwert T; Hocke C; Prante O
Molecules; 2016 Aug; 21(9):. PubMed ID: 27589704
[TBL] [Abstract][Full Text] [Related]
15. Radiosynthesis and Radiotracer Properties of a 7-(2-[18F]Fluoroethoxy)-6-methoxypyrrolidinylquinazoline for Imaging of Phosphodiesterase 10A with PET.
Funke U; Deuther-Conrad W; Schwan G; Maisonial A; Scheunemann M; Fischer S; Hiller A; Briel D; Brust P
Pharmaceuticals (Basel); 2012 Feb; 5(2):169-88. PubMed ID: 24288087
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of [(18)F]JNJ42259152 as a PET tracer for PDE10A.
Celen S; Koole M; Ooms M; De Angelis M; Sannen I; Cornelis J; Alcazar J; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
Neuroimage; 2013 Nov; 82():13-22. PubMed ID: 23664955
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor.
de Oliveira SK; Hoffmeister M; Gambaryan S; Müller-Esterl W; Guimaraes JA; Smolenski AP
J Biol Chem; 2007 May; 282(18):13656-63. PubMed ID: 17329248
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Evaluation of
Declercq L; Rombouts F; Koole M; Fierens K; Mariën J; Langlois X; Andrés JI; Schmidt M; Macdonald G; Moechars D; Vanduffel W; Tousseyn T; Vandenberghe R; Van Laere K; Verbruggen A; Bormans G
J Nucl Med; 2017 Jun; 58(6):975-981. PubMed ID: 28232614
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 2A inhibition corrects the aberrant behavioral traits observed in genetic and environmental preclinical models of Autism Spectrum Disorder.
Schiavi S; Carbone E; Melancia F; di Masi A; Jarjat M; Brau F; Cardarelli S; Giorgi M; Bardoni B; Trezza V
Transl Psychiatry; 2022 Mar; 12(1):119. PubMed ID: 35338117
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a highly specific
Xiao Z; Wei H; Xu Y; Haider A; Wei J; Yuan S; Rong J; Zhao C; Li G; Zhang W; Chen H; Li Y; Zhang L; Sun J; Zhang S; Luo HB; Yan S; Cai Q; Hou L; Che C; Liang SH; Wang L
Acta Pharm Sin B; 2022 Apr; 12(4):1963-1975. PubMed ID: 35847497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
